| JCICM-39-02: Research and Development of a New TCM-based Antidepressant |
|
Principal Investigator: |
Prof. HF Kung |
Project Coordinators: |
Prof. LD Kong |
Research Partner: |
The Chinese University of Hong Kong |
|
Project Background
There are about 700 million peoples suffering from depression in the world, and 15% of patients have a tendency toward committing suicide. With the multiple target approach of the TCM theory, this project aims to develop a new safer and effective anti-depression medicine.
Special Product Features / Technical Excellence
- An innovative formulation in which the active fractions and ingredients are well documented
- Modern extraction technology utilized to maximize the collection of active fractions and ingredients from Chinese medicinal herbs
- QC methodologies including fingerprint spectra established to assess and assure the quality of preparation
Intellectual Properties & Regulatory Filings
- Patent pending: PRC and Hong Kong
- To file China IND
 Related Publications
|
|
About Us
